Abstract Background Volatile organic compounds [VOCs] show promise as potential
biomarkers of for ulcerative colitis and Crohn's disease, two chronic, idiopathic …

Background: Volatile organic compounds (VOCs) show promise as potential biomarkers of
for ulcerative colitis and Crohn's disease, two chronic idiopathic gastrointestinal disorders …

Introduction: Inflammatory bowel disease (IBD) is a common disease with significant
morbidity. Noninvasive diagnostic techniques are lacking in IBD. Currently, fecal calprotectin …

Background To optimise treatment of ulcerative colitis (UC), patients need repeated
assessment of mucosal inflammation. Current non‐invasive biomarkers and clinical activity …

The diagnosis of inflammatory bowel disease (IBD) remains a challenging task despite
significant increase in the understanding of the disease aetiology and pathogenesis. Recent …

Volatile organic compounds (VOCs) are produced by the human metabolism, inflammation
and gut microbiota and form the basis of innovative volatomics research. VOCs detected …

Introduction VOCs can be utilised as non invasive biomarkers for gastrointestinal diseases
such as IBD, as changes in VOCs reflect internal metabolical and pathological processes …

Background Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disease
characterized by intermittent abdominal pain with altered bowel habits. Due to the …

Simple Summary Early diagnosis is crucial for reducing colorectal cancer-related mortality in
both the general population and inflammatory bowel disease. Volatile organic compound …

Background The aetiology of inflammatory bowel disease (IBD) remains poorly understood.
Recent evidence suggests an important role of gut microbial dysbiosis in IBD, and this may …